Reuters reports the new generics come from Hetero Labs after the original Obeda was recalled over an impurity. Dr Reddy's says the launches were planned well before.
Recap by typeshit. Full story at Yahoo Finance Singapore.
A Facebook user criticizes telehealth marketing of tirzepatide and other GLP-1 services that targets new mothers, calling it predatory. One person's opinion.
Dr. Noc joined StarTalk to cover GLP-1 drugs, creatine, peptides and looksmaxxing. The full talk is out on YouTube and in podcast apps.
The obesity doctor says commenters once treated her early support for these medications as heresy. She adds that she saw their potential back in 2005.
A TikTok playlist collects GLP-1 updates from creator @stephaniemua1. There is no detail on what the videos cover beyond the playlist name.
L'Oréal's CEO told investors GLP-1s are shifting skincare buying, while Carlsberg and Diageo play down any hit to beer demand.
The Korean drugmaker says it will show two sets of findings on its oral semaglutide for obesity and diabetes at the AAPS annual meeting.
Loading…